In line with our results, decreases in NPTX2 and VGF have previously been associated with worse cognition in non-demented individuals with AD and conversion to dementia (Libiger et al., 2021; Llano et al., 2023; Llano et al., 2019). The gene discussed is NPTX2; the disease is Alzheimer disease.